If Titan was planning to go this alone, they would have made a switch at CEO but I don't believe they have any intention of doing that. As someone pointed out JH is well connected and imo is in place to guide Titan thru the M/A process. That is what Bertner is doing (She/her company is not a web design company nor a PR company - check their website, no mention of PR or website design). Titan has $37M to put into more applications and design freeze, once those are accomplished then Titan hopefully goes to highest bidder. All the charts and technical analysis is helpful if trading on a day to day basis but Titan mgmt doesn't manage to the day to day news and certainly not interested in current PPS. They are focused on the sell, everything they don't do indicates to me that selling is their objective.
Another note, the transenterix news is very good for TITXF. Surgibot will have a place in robotics but SPORT will be that next step up. Once TRXC is approved then the FDA approval process will be that much easier for TITXF to navigate. While I am not happy with the delay, I can see where TItan mgmt saw that TRXC was close to being that second robot on the market and decided to let them wrestle with the FDA on approval. Seeing how the FDA handles TRXC will help Titan/Ximedica a great deal and probably shorten their FDA approval process b/c you will have "Similar" devices on the market rather than just one.
